IT1263076B - Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
- Google Patents
Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
Info
Publication number
IT1263076B
IT1263076BITFI930069AITFI930069AIT1263076BIT 1263076 BIT1263076 BIT 1263076BIT FI930069 AITFI930069 AIT FI930069AIT FI930069 AITFI930069 AIT FI930069AIT 1263076 BIT1263076 BIT 1263076B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ITFI930069ApriorityCriticalpatent/IT1263076B/it
Publication of ITFI930069A0publicationCriticalpatent/ITFI930069A0/it
Publication of ITFI930069A1publicationCriticalpatent/ITFI930069A1/it
Application grantedgrantedCritical
Publication of IT1263076BpublicationCriticalpatent/IT1263076B/it
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
ITFI930069A1993-04-061993-04-06Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
IT1263076B
(it)
Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)